Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient
NCT02338778
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Liver Neoplasms
Interventions
BIOLOGICAL:
MV
OTHER:
Standard Treatment
Sponsor
Fuda Cancer Hospital, Guangzhou